| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $94.5M | +73.8% |
| SG&A Expense | $31.1M | +68.8% |
| Operating Income | -$125.6M | -72.5% |
| Pre-tax Income | -$123.7M | -70.1% |
| Income Tax | $0 | — |
| Net Income | -$123.7M | -70.1% |
| EPS (Basic) | -$2.76 | +32.7% |
| EPS (Diluted) | -$2.76 | +32.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $95.3M | +149.9% |
| Short-term Investments | $91.3M | -57.2% |
| Current Assets | $193.8M | -24.1% |
| Total Assets | $278.9M | -11.2% |
| Current Liabilities | $24.2M | +11.4% |
| Total Liabilities | $35.6M | -0.3% |
| Stockholders' Equity | $243.4M | -12.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$104.4M | -71.7% |
| Capital Expenditures | $20.6M | -17.9% |
| Investing Cash Flow | $83.7M | +135.1% |
| Financing Cash Flow | $77.8M | -62.8% |
| Free Cash Flow | -$125.1M | -45.5% |